Xiangpeng Dai
- Molecular Biology top 5%
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 5%
- Immunology top 10%
- Co-authors
- Wenyi WeiJianping GuoJinfang ZhangLixin WanFei WuBrian J. NorthYanpeng CiHiroyuki Inuzuka
- Topics
- Ubiquitin and proteasome pathways (15 papers)Histone Deacetylase Inhibitors Research (6 papers)Cancer-related Molecular Pathways (6 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Xiangpeng Dai
29 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Molecular Biology 1.5k
- Oncology 838
- Pulmonary and Respiratory Medicine 404
- Cancer Research 361
- Immunology 329
Countries citing papers authored by Xiangpeng Dai
This map shows the geographic impact of Xiangpeng Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangpeng Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangpeng Dai more than expected).
Fields of papers citing papers by Xiangpeng Dai
This network shows the impact of papers produced by Xiangpeng Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangpeng Dai. The network helps show where Xiangpeng Dai may publish in the future.
Co-authorship network of co-authors of Xiangpeng Dai
This figure shows the co-authorship network connecting the top 25 collaborators of Xiangpeng Dai. A scholar is included among the top collaborators of Xiangpeng Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangpeng Dai. Xiangpeng Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 36 | |
| 3 | 76 | |
| 4 | 114 | |
| 5 | Cyclin D–CDK4 kinase destabilizes PD-L1 via cullin 3–SPOP to control cancer immune surveillancebreakdown → | 736 |
| 6 | 37 | |
| 7 | 149 | |
| 8 | 60 | |
| 9 | 30 | |
| 10 | 42 | |
| 11 | 26 | |
| 12 | SPOP Promotes Ubiquitination and Degradation of the ERG Oncoprotein to Suppress Prostate Cancer Progression | 1 |
| 13 | 36 | |
| 14 | 153 | |
| 15 | 133 | |
| 16 | 83 | |
| 17 | 117 | |
| 18 | 117 | |
| 19 | 10 | |
| 20 | 19 |
About Xiangpeng Dai
Xiangpeng Dai is a scholar working on Cancer Research, Cell Biology and Molecular Biology, having authored 29 papers that have together received 2.2k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (15 papers), Histone Deacetylase Inhibitors Research (6 papers) and Cancer-related Molecular Pathways (6 papers). The work is most often cited by research in Oncology (838 citations), Cancer Research (361 citations) and Molecular Biology (1.5k citations). Xiangpeng Dai has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Wenyi Wei, Jianping Guo, Jinfang Zhang, Lixin Wan, Fei Wu, Brian J. North, Yanpeng Ci, Hiroyuki Inuzuka, Yuyong Tan and Yinghao Sun. Their work appears in journals such as Nature, Nature Communications and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.